Grindeks's sales growth in 2008
This article was originally published in Scrip
Executive Summary
The sales of Latvia's largest pharmaceutical company Grindeks grew by 21% to Ls62.1 million ($112.5 million) last year. Its pre-tax profit increased by 25% to Ls10.8 million, and its net profit was up by 27% to Ls9 million.